Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Steer clear of the worst practices in cryptocurrency investing to protect your assets. Learn from common mistakes.
12,710 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
When a large investment firm trims a position, it sends a signal to the market. This article explains what timucuan a...
Private AI secondaries are heating up as Anthropic eyes a potential IPO. Market chatter warns the scene is a pressure...
IBM is capturing attention this week with a blend of quantum computing momentum and AI-powered cybersecurity initiati...
A nationwide labor crunch is tightening the screws on U.S. construction as immigrant workers pull back amid policy ch...
Want real estate exposure without being a landlord? This lazy investor’s guide real explores how syndications let you...
Nvidia posted solid earnings as hyperscalers accelerate AI builds. CFO Colette Kress flagged rising GPU rental costs,...
A single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...
NVIDIA is more than a chip maker; it’s the AI backbone for modern computing. This guide explains why NVIDIA still art...
When markets tumble, the real opportunity is buying strong businesses at lower prices. Here are three reliable picks ...
Pony AI's Q1 2026 earnings transcript is a pivotal moment for investors. This article breaks down the key numbers, th...
Tech stocks are leading the charge, lifting major indices to new highs. This guide breaks down the drivers, the bigge...